MXPA03008110A - Mutantes de interleucina-18, su produccion y uso. - Google Patents
Mutantes de interleucina-18, su produccion y uso.Info
- Publication number
- MXPA03008110A MXPA03008110A MXPA03008110A MXPA03008110A MXPA03008110A MX PA03008110 A MXPA03008110 A MX PA03008110A MX PA03008110 A MXPA03008110 A MX PA03008110A MX PA03008110 A MXPA03008110 A MX PA03008110A MX PA03008110 A MXPA03008110 A MX PA03008110A
- Authority
- MX
- Mexico
- Prior art keywords
- mutants
- interleukin
- production
- molecule
- wild type
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27432701P | 2001-03-08 | 2001-03-08 | |
| PCT/IB2002/002344 WO2002101049A2 (en) | 2001-03-08 | 2002-03-08 | Interleukin-18 mutants, their production and use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA03008110A true MXPA03008110A (es) | 2003-12-12 |
Family
ID=23047735
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA03008110A MXPA03008110A (es) | 2001-03-08 | 2002-03-08 | Mutantes de interleucina-18, su produccion y uso. |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US7524488B2 (es) |
| EP (1) | EP1392830B1 (es) |
| JP (1) | JP2004530432A (es) |
| KR (1) | KR100862136B1 (es) |
| CN (1) | CN100503829C (es) |
| AT (1) | ATE315647T1 (es) |
| AU (1) | AU2002324249B2 (es) |
| BR (1) | BRPI0207933B8 (es) |
| CA (1) | CA2438851C (es) |
| DE (1) | DE60208692T2 (es) |
| DK (1) | DK1392830T3 (es) |
| EA (1) | EA005769B1 (es) |
| ES (1) | ES2251610T3 (es) |
| HK (1) | HK1084151A1 (es) |
| IL (2) | IL157800A0 (es) |
| MX (1) | MXPA03008110A (es) |
| SI (1) | SI1392830T1 (es) |
| UA (1) | UA79235C2 (es) |
| WO (1) | WO2002101049A2 (es) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE602004031341D1 (de) | 2003-07-21 | 2011-03-24 | Transgene Sa | Multifunktionelle cytokine |
| WO2005014642A2 (en) * | 2003-07-21 | 2005-02-17 | Transgene S.A. | Novel multifunctional cytokines |
| PT1689777E (pt) * | 2003-11-05 | 2007-05-31 | Ares Trading Sa | Processo para a purificação da proteína de ligação a il-18 |
| US7557084B2 (en) * | 2004-03-31 | 2009-07-07 | Regeneron Pharmaceuticals, Inc. | IL-18 specific polypeptides and therapeutic uses thereof |
| CA2609060C (en) | 2005-06-03 | 2014-07-15 | Urs Weber | Production of recombinant il-18 binding protein |
| PT1891088E (pt) | 2005-06-10 | 2011-12-19 | Ares Trading Sa | Processo para a purificação da proteína de ligação il-18 |
| CN101177454B (zh) * | 2007-05-09 | 2010-09-22 | 郑骏年 | Il-18突变体多肽及制备及用途 |
| WO2012078936A2 (en) * | 2010-12-10 | 2012-06-14 | Glaxosmithkline Llc | Methods to produce a purified peptide chain fraction |
| IL305370A (en) * | 2017-09-06 | 2023-10-01 | Univ Yale | Variants of interleukin-18 and methods of use |
| US12029778B2 (en) | 2019-05-13 | 2024-07-09 | Yale University | Interleukin-18 mimics and methods of use |
| JP2021170968A (ja) * | 2020-04-22 | 2021-11-01 | 国立大学法人 長崎大学 | マウスｉｌ−１８の製造方法及びそのための組換えｄｎａ |
| CA3189327A1 (en) * | 2020-08-19 | 2022-02-24 | Vijaya Raghavan PATTABIRAMAN | Modified il-18 polypeptides and uses thereof |
| WO2022094473A1 (en) | 2020-11-02 | 2022-05-05 | Simcha IL-18, Inc. | Interleukin-18 variants and methods of use |
| WO2022172944A1 (ja) * | 2021-02-10 | 2022-08-18 | 国立大学法人 長崎大学 | 新規ヒトインターロイキン－１８変異体及びその用途 |
| WO2023010021A1 (en) | 2021-07-27 | 2023-02-02 | Xencor, Inc. | Il-18-fc fusion proteins |
| JP2023024168A (ja) | 2021-08-06 | 2023-02-16 | 国立大学法人 長崎大学 | がんの治療剤 |
| WO2023056193A2 (en) * | 2021-09-29 | 2023-04-06 | Chimera Bioengineering, Inc. | Il-18 variants and uses thereof |
| WO2023118497A1 (en) * | 2021-12-22 | 2023-06-29 | Pieris Pharmaceuticals Gmbh | Novel il-18 variants |
| US20230355795A1 (en) * | 2022-02-23 | 2023-11-09 | Bright Peak Therapeutics Ag | Immune antigen specific il-18 immunocytokines and uses thereof |
| WO2023161853A1 (en) | 2022-02-23 | 2023-08-31 | Bright Peak Therapeutics Ag | Activatable il-18 polypeptides |
| AU2023224445A1 (en) * | 2022-02-23 | 2024-08-29 | Bright Peak Therapeutics Ag | Modified il-18 polypeptides |
| WO2024044780A1 (en) * | 2022-08-26 | 2024-02-29 | Sutro Biopharma, Inc. | Interleukin-18 variants and uses thereof |
| WO2024102693A2 (en) | 2022-11-07 | 2024-05-16 | Xencor, Inc. | Il-18-fc fusion proteins |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4024366B2 (ja) * | 1996-11-29 | 2007-12-19 | 株式会社林原生物化学研究所 | ポリペプチド |
| TWI227136B (en) * | 1998-05-21 | 2005-02-01 | Smithkline Beecham Corp | Novel pharmaceutical composition for the prevention and/or treatment of cancer |
| IL129427A0 (en) | 1999-04-13 | 2000-02-17 | Yeda Res & Dev | Preparation of biologically active molecules |
-
2002
- 2002-03-08 KR KR1020037011581A patent/KR100862136B1/ko active IP Right Grant
- 2002-03-08 CA CA2438851A patent/CA2438851C/en not_active Expired - Lifetime
- 2002-03-08 JP JP2003503799A patent/JP2004530432A/ja active Pending
- 2002-03-08 WO PCT/IB2002/002344 patent/WO2002101049A2/en active IP Right Grant
- 2002-03-08 AT AT02758668T patent/ATE315647T1/de active
- 2002-03-08 EA EA200300987A patent/EA005769B1/ru not_active IP Right Cessation
- 2002-03-08 US US10/094,153 patent/US7524488B2/en not_active Expired - Lifetime
- 2002-03-08 SI SI200230280T patent/SI1392830T1/sl unknown
- 2002-03-08 DE DE60208692T patent/DE60208692T2/de not_active Expired - Lifetime
- 2002-03-08 AU AU2002324249A patent/AU2002324249B2/en not_active Expired
- 2002-03-08 MX MXPA03008110A patent/MXPA03008110A/es active IP Right Grant
- 2002-03-08 BR BRPI0207933-0 patent/BRPI0207933B8/pt not_active IP Right Cessation
- 2002-03-08 CN CNB02809803XA patent/CN100503829C/zh not_active Expired - Lifetime
- 2002-03-08 DK DK02758668T patent/DK1392830T3/da active
- 2002-03-08 ES ES02758668T patent/ES2251610T3/es not_active Expired - Lifetime
- 2002-03-08 EP EP02758668A patent/EP1392830B1/en not_active Expired - Lifetime
- 2002-03-08 IL IL15780002A patent/IL157800A0/xx unknown
- 2002-08-03 UA UA2003109084A patent/UA79235C2/uk unknown
-
2003
- 2003-09-08 IL IL157800A patent/IL157800A/en unknown
-
2006
- 2006-06-06 HK HK06106439.0A patent/HK1084151A1/xx not_active IP Right Cessation
-
2009
- 2009-03-16 US US12/404,458 patent/US7875709B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| BR0207933A (pt) | 2004-03-02 |
| ATE315647T1 (de) | 2006-02-15 |
| WO2002101049A3 (en) | 2003-12-18 |
| IL157800A (en) | 2009-08-03 |
| CN100503829C (zh) | 2009-06-24 |
| JP2004530432A (ja) | 2004-10-07 |
| AU2002324249B2 (en) | 2007-04-05 |
| SI1392830T1 (sl) | 2006-06-30 |
| EA200300987A1 (ru) | 2004-02-26 |
| DK1392830T3 (da) | 2006-05-08 |
| KR100862136B1 (ko) | 2008-10-09 |
| US20090286855A1 (en) | 2009-11-19 |
| UA79235C2 (en) | 2007-06-11 |
| DE60208692D1 (de) | 2006-04-06 |
| HK1084151A1 (en) | 2006-07-21 |
| DE60208692T2 (de) | 2006-07-13 |
| WO2002101049A2 (en) | 2002-12-19 |
| CN1764723A (zh) | 2006-04-26 |
| US20020169291A1 (en) | 2002-11-14 |
| CA2438851A1 (en) | 2002-12-19 |
| ES2251610T3 (es) | 2006-05-01 |
| EP1392830A2 (en) | 2004-03-03 |
| CA2438851C (en) | 2011-07-26 |
| US7875709B2 (en) | 2011-01-25 |
| BRPI0207933B1 (pt) | 2020-11-24 |
| EA005769B1 (ru) | 2005-06-30 |
| BRPI0207933B8 (pt) | 2021-05-25 |
| IL157800A0 (en) | 2004-03-28 |
| US7524488B2 (en) | 2009-04-28 |
| KR20030088448A (ko) | 2003-11-19 |
| EP1392830B1 (en) | 2006-01-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1084151A1 (en) | Interleukin-18 mutants, their production and use | |
| AU2002254876A1 (en) | Alpha-amylase variant with altered properties | |
| IL195338A0 (en) | Optimized fc variants and methods for their generation | |
| EP1476180A4 (en) | INTERLEUKIN-2 MUTANTS WITH REDUCED TOXICITY | |
| GB2383623B (en) | Variable rate multi-arc composite leaf spring assembly | |
| MXPA04002562A (es) | Combinacion de un pde-4 y nsaid. | |
| WO2004007664A3 (en) | Nucleic acid vectors | |
| MY149864A (en) | Flavouring-containing pharmaceutical formulations with improved pharmaceutical properties | |
| SG146640A1 (en) | Isolated photoprotein mtclytin, and use thereof | |
| HK1082510A1 (en) | Promoter to il-18bp, its preparation and use | |
| AU2003259750A1 (en) | Methods and compositions for targeting secretory lysosomes | |
| WO2004111196A3 (en) | Mutants of core 2 b-1,6-n-acetylglycosaminyltransferase | |
| AU2002361023A1 (en) | Stabilizer composition, production and use thereof | |
| MXPA05007793A (es) | Composiciones de nucleotidos enlazados con alquilo. | |
| TWI316091B (es) | ||
| WO2005057486A3 (en) | Protein engineering with analogous contact environments | |
| ATE405668T1 (de) | Exopolysaccharidproduktion | |
| TW200519206A (en) | Methods for producing novel medaka and novel medaka | |
| WO2003027321A3 (en) | Methods for diagnosis and treatment of diseases associated with altered expression of neurogranin | |
| PL373538A1 (en) | Alkoxy-substituted indanes and the production thereof | |
| BR8201310U (pt) | Estofados de estrutura metálica | |
| MY143213A (en) | Ifnar2 mutants, their production and use | |
| ZA200203720B (en) | High caratage gold alloys with increased hardness. | |
| UA30360A (uk) | N-ацетіл-l-цистеїн, який має протиаритмічні властивості |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |